PharmPK Discussion - Vanco clearance from dialysis membranes

• On 9 Jul 1996 at 09:29:33, Randy3658.aaa.aol.com sent the message
  

  
  I read an article recently about some newer membranes used in dialysis
  removing vanco to a higher degree than what older dialysis equipment did.  I
  can't seem to locate where I read this article.  Does anyone else recall
  recently reading of this and if so could you give the the reference info?
  
  Thanks
  Randy3658.aaa.aol.com
  
  

  Back to the Top

• On 10 Jul 1996 at 11:17:21, Joan Korth-Bradley (KorthBJ.aaa.war.wyeth.com) sent the message
  

  
  Matzke GR, Pharmacotherapeutic consequences of recent advances in
  hemodialysis therapy.  Annals of Pharmacotherapy 1994;28:512-14.
  contains a reference of this type.
  
  Joan K-B
  
  

  Back to the Top

• On 11 Jul 1996 at 09:36:08, "Frye, Reggie" (frye.-at-.druginfonet.pharm-epid.pitt.edu) sent the message
  

  
  Here are some useful references I have on the topic:
  
  Bastani B, Spyker DA, Minocha A, Cummings R, Westervelt FB:  In vivo
  comparison of three different hemodialysis membranes for vancomycin
  clearance: cuprophan, cellulose acetate and polyacrylonitrile.
  Dialysis Transplantation 1988;17:527-543.
  
  Lanese DM, Alfrey PS, Molitoris BA:  Markedly increased clearance of
  vancomycin during hemodialysis using polysulfone dialyzers.  Kidney
  Int 1989;35:1409-1412.
  
  Torras J, Cao C, Rivas MC, Cano M, Fernandez E. Montuliu J:
  Pharmacokinetics of vancomycin in patients undergoing hemodialysis
  with polyacrylonitrile.  Clin Nephrol 1991;36:35-41.
  
  DeSoi CA, Sahm DF, Umans JG:  Vancomycin in elimination during
  high-flux hemodiaylsis; kinetic model and comparison of four
  membranes.  Am J Kidney Dis 1992;20:354-360.
  
  Barth RH, DeVincenzo N, Zara AC, Berlyne GM:  Vancomycin
  pharmacokinetics in high-flux hemodialysis.  J Am Soc Nephrol
  1990;1(4):387.  Abstract.
  
  Schoumacher R, Chevalier RL, Gomez RA, Rogol AD, Cummings R, Spyker
  DA:  Enhanced clearance of vancomycin by hemodialysis in a child.
  Pediatr Nephrol 1989;3:83-85.
  
  Quale JM, O'Halloran JJ, DeVincenzo N, Barth RH:  Removal of
  vancomycin by high-flux hemodialysis membranes.  Antimicrob Agents
  Chemother 1992;36:1424-1426.
  
  Pollard TA, Lampasona V, Akkerman S, et al:  Vancomycin
  redistribution: dosing recommendations following high-flux
  hemodialysis.  Kidney Int 1994;45:232-237.
  
  Touchette MA, Patel RV, Anandan JV, Dumler F, Zarowitz BJ:  Vancomycin
  removal by high-flux polysulfone hemodialysis membranes in critically
  ill patients with end-stage renal disease.  Am J Kidney Dis
  1995;26:469-474.
  
  Bohler J, Reetze-Bonorden P, Keller E, Kramer A, Schollmeyer PJ:
  Rebound of plasma vancomycin levels after haemodialysis with highly
  permeable membranes.  Eur J Clin Pharmacol 1992;42:635-640.
  
  Welage LS, Mason NA, Hoffman EJ:  Influence of cellulose triacetate
  hemodialyzers on vancomycin pharmacokinetics.  J Am Soc Nephrol
  1995;6:1284-1290.
  
  Reggie Frye
  
  

  Back to the Top

• On 11 Jul 1996 at 09:36:10, "Budris, Bill" (BBudris.at.WESLEY.NMH.NMH.ORG) sent the message
  

  
  See June 1, 1996 AJHP, p 1339, Letter: More information on vancomycin
  clearance by new hemodialysis membranes.
  
  Bill (NMH)
  
  

  Back to the Top

Copyright 1995-2014 David W. A. Bourne (david@boomer.org)